Strong New Drug Sales Lift Mayne Pharma

Manufacturer and distributor of pharmaceuticals, Mayne Pharma ((MYX)), is continuing its transformation and now has a portfolio of branded and generic medicines which have elevated it to a substantial player globally. The company has more development capability and directly distributes into the US. The market for generic medicines in the US is estimated to be at a US$60bn, and growing.

Read More